Clinical utility of HPV genotyping (Q36578289)

15 August 2017

1 reference

title

Clinical utility of HPV genotyping (English)

1 reference

15 August 2017

1 reference

3

Philip E Castle

1 reference

15 August 2017

Chris J Meijer

1

1 reference

15 August 2017

Peter J Snijders

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

24 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

103

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

12-17

1 reference

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Carcinogenicity of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Management of women who test positive for high-risk types of human papillomavirus: the HART study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

A study of the impact of adding HPV types to cervical cancer screening and triage tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

The carcinogenicity of human papillomavirus types reflects viral evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2006.07.031

10.1016/J.YGYNO.2006.07.031

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference